SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
|
INSIGHT MOLECULAR DIAGNOSTICS INC. |
|
|
Date: May 13, 2026 |
/s/ Joshua Riggs |
|
Joshua Riggs |
|
President and Chief Executive Officer (Principal Executive Officer) |
|
|
Date: May 13, 2026 |
/s/ Andrea James |
|
Andrea James |
|
Chief Financial Officer (Principal Financial Officer) |
